What is EDTA Oral Chelating Formula and how does it work?

Chelating therapy was originally developed by the U.S. Navy in the 1940’s to treat deep-sea divers suffering from lead poisoning.

Chelation therapy involves the use of EDTA (ethylene diamine tetra-acetic acid), a synthetic amino acid. EDTA, which effectively speeds removal of heavy metals and minerals such as lead, iron, copper, and calcium from the blood, is approved by the U.S. Food and Drug Administration (FDA) for use in treating lead poisoning and toxicity from other heavy metals.

Chelating therapy takes its name from Khele; the Greek word for claw. As the name implies, EDTA has the ability to grab onto, or bind to, heavy metals in the body in such a way as to allow the body to excrete these toxins.

There is increasing evidence EDTA Chelation as an effective way to treat coronary artery disease (CAD). CAD is a type of heart disease in which the coronary arteries (vessels that supply oxygen-carrying blood to the heart) become blocked by deposits of a fatty substance called plaque. As plaque builds, the arteries become narrower, and less oxygen and fewer nutrients are transported to the heart for proper function. CAD can lead to serious health problems such as angina (pain caused by insufficient oxygen-carrying blood reaching the heart) and heart attack.